 | • レポートコード：MRC308GR11456 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の切迫性尿失禁治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の切迫性尿失禁治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 切迫性尿失禁治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
切迫性尿失禁治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・抗コリン薬、β3刺激薬、その他
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Pfizer、Johnson & Johnson、Merck、Novartis、GlaxoSmithKline、Astellas Pharma、Teva Pharmaceutical、Mylan、AbbVie、Sanofi
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、切迫性尿失禁治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な切迫性尿失禁治療薬メーカーの企業概要、2019年～2022年までの切迫性尿失禁治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な切迫性尿失禁治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別切迫性尿失禁治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの切迫性尿失禁治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での切迫性尿失禁治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および切迫性尿失禁治療薬の産業チェーンを掲載しています。
・第14、15章では、切迫性尿失禁治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 切迫性尿失禁治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：抗コリン薬、β3刺激薬、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界の切迫性尿失禁治療薬市場規模・予測
– 世界の切迫性尿失禁治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Johnson & Johnson、Merck、Novartis、GlaxoSmithKline、Astellas Pharma、Teva Pharmaceutical、Mylan、AbbVie、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：抗コリン薬、β3刺激薬、その他
・用途別分析2018年-2029年：病院、診療所、その他
・切迫性尿失禁治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・切迫性尿失禁治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・切迫性尿失禁治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・切迫性尿失禁治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・切迫性尿失禁治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Medicines for Urge Incontinence
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medicines for Urge Incontinence Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Anticholinergics
1.3.3 Beta-3 Agonists
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Medicines for Urge Incontinence Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Medicines for Urge Incontinence Market Size & Forecast
1.5.1 Global Medicines for Urge Incontinence Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medicines for Urge Incontinence Sales Quantity (2018-2029)
1.5.3 Global Medicines for Urge Incontinence Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Medicines for Urge Incontinence Product and Services
2.1.4 Pfizer Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Medicines for Urge Incontinence Product and Services
2.2.4 Johnson & Johnson Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Medicines for Urge Incontinence Product and Services
2.3.4 Merck Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Medicines for Urge Incontinence Product and Services
2.4.4 Novartis Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Medicines for Urge Incontinence Product and Services
2.5.4 GlaxoSmithKline Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Astellas Pharma
2.6.1 Astellas Pharma Details
2.6.2 Astellas Pharma Major Business
2.6.3 Astellas Pharma Medicines for Urge Incontinence Product and Services
2.6.4 Astellas Pharma Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Astellas Pharma Recent Developments/Updates
2.7 Teva Pharmaceutical
2.7.1 Teva Pharmaceutical Details
2.7.2 Teva Pharmaceutical Major Business
2.7.3 Teva Pharmaceutical Medicines for Urge Incontinence Product and Services
2.7.4 Teva Pharmaceutical Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teva Pharmaceutical Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Medicines for Urge Incontinence Product and Services
2.8.4 Mylan Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business
2.9.3 AbbVie Medicines for Urge Incontinence Product and Services
2.9.4 AbbVie Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AbbVie Recent Developments/Updates
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Medicines for Urge Incontinence Product and Services
2.10.4 Sanofi Medicines for Urge Incontinence Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi Recent Developments/Updates
3 Competitive Environment: Medicines for Urge Incontinence by Manufacturer
3.1 Global Medicines for Urge Incontinence Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medicines for Urge Incontinence Revenue by Manufacturer (2018-2023)
3.3 Global Medicines for Urge Incontinence Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medicines for Urge Incontinence by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medicines for Urge Incontinence Manufacturer Market Share in 2022
3.4.2 Top 6 Medicines for Urge Incontinence Manufacturer Market Share in 2022
3.5 Medicines for Urge Incontinence Market: Overall Company Footprint Analysis
3.5.1 Medicines for Urge Incontinence Market: Region Footprint
3.5.2 Medicines for Urge Incontinence Market: Company Product Type Footprint
3.5.3 Medicines for Urge Incontinence Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medicines for Urge Incontinence Market Size by Region
4.1.1 Global Medicines for Urge Incontinence Sales Quantity by Region (2018-2029)
4.1.2 Global Medicines for Urge Incontinence Consumption Value by Region (2018-2029)
4.1.3 Global Medicines for Urge Incontinence Average Price by Region (2018-2029)
4.2 North America Medicines for Urge Incontinence Consumption Value (2018-2029)
4.3 Europe Medicines for Urge Incontinence Consumption Value (2018-2029)
4.4 Asia-Pacific Medicines for Urge Incontinence Consumption Value (2018-2029)
4.5 South America Medicines for Urge Incontinence Consumption Value (2018-2029)
4.6 Middle East and Africa Medicines for Urge Incontinence Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
5.2 Global Medicines for Urge Incontinence Consumption Value by Type (2018-2029)
5.3 Global Medicines for Urge Incontinence Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
6.2 Global Medicines for Urge Incontinence Consumption Value by Application (2018-2029)
6.3 Global Medicines for Urge Incontinence Average Price by Application (2018-2029)
7 North America
7.1 North America Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
7.2 North America Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
7.3 North America Medicines for Urge Incontinence Market Size by Country
7.3.1 North America Medicines for Urge Incontinence Sales Quantity by Country (2018-2029)
7.3.2 North America Medicines for Urge Incontinence Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
8.2 Europe Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
8.3 Europe Medicines for Urge Incontinence Market Size by Country
8.3.1 Europe Medicines for Urge Incontinence Sales Quantity by Country (2018-2029)
8.3.2 Europe Medicines for Urge Incontinence Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medicines for Urge Incontinence Market Size by Region
9.3.1 Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medicines for Urge Incontinence Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
10.2 South America Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
10.3 South America Medicines for Urge Incontinence Market Size by Country
10.3.1 South America Medicines for Urge Incontinence Sales Quantity by Country (2018-2029)
10.3.2 South America Medicines for Urge Incontinence Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medicines for Urge Incontinence Market Size by Country
11.3.1 Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medicines for Urge Incontinence Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Medicines for Urge Incontinence Market Drivers
12.2 Medicines for Urge Incontinence Market Restraints
12.3 Medicines for Urge Incontinence Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Medicines for Urge Incontinence and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medicines for Urge Incontinence
13.3 Medicines for Urge Incontinence Production Process
13.4 Medicines for Urge Incontinence Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medicines for Urge Incontinence Typical Distributors
14.3 Medicines for Urge Incontinence Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Medicines for Urge Incontinence Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medicines for Urge Incontinence Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Medicines for Urge Incontinence Product and Services
Table 6. Pfizer Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Medicines for Urge Incontinence Product and Services
Table 11. Johnson & Johnson Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Medicines for Urge Incontinence Product and Services
Table 16. Merck Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Medicines for Urge Incontinence Product and Services
Table 21. Novartis Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Medicines for Urge Incontinence Product and Services
Table 26. GlaxoSmithKline Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Astellas Pharma Major Business
Table 30. Astellas Pharma Medicines for Urge Incontinence Product and Services
Table 31. Astellas Pharma Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Astellas Pharma Recent Developments/Updates
Table 33. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Teva Pharmaceutical Major Business
Table 35. Teva Pharmaceutical Medicines for Urge Incontinence Product and Services
Table 36. Teva Pharmaceutical Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Teva Pharmaceutical Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Medicines for Urge Incontinence Product and Services
Table 41. Mylan Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mylan Recent Developments/Updates
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Medicines for Urge Incontinence Product and Services
Table 46. AbbVie Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AbbVie Recent Developments/Updates
Table 48. Sanofi Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi Major Business
Table 50. Sanofi Medicines for Urge Incontinence Product and Services
Table 51. Sanofi Medicines for Urge Incontinence Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanofi Recent Developments/Updates
Table 53. Global Medicines for Urge Incontinence Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Medicines for Urge Incontinence Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Medicines for Urge Incontinence Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Medicines for Urge Incontinence, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Medicines for Urge Incontinence Production Site of Key Manufacturer
Table 58. Medicines for Urge Incontinence Market: Company Product Type Footprint
Table 59. Medicines for Urge Incontinence Market: Company Product Application Footprint
Table 60. Medicines for Urge Incontinence New Market Entrants and Barriers to Market Entry
Table 61. Medicines for Urge Incontinence Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Medicines for Urge Incontinence Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Medicines for Urge Incontinence Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Medicines for Urge Incontinence Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Medicines for Urge Incontinence Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Medicines for Urge Incontinence Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Medicines for Urge Incontinence Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Medicines for Urge Incontinence Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Medicines for Urge Incontinence Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Medicines for Urge Incontinence Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Medicines for Urge Incontinence Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Medicines for Urge Incontinence Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Medicines for Urge Incontinence Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Medicines for Urge Incontinence Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Medicines for Urge Incontinence Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Medicines for Urge Incontinence Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Medicines for Urge Incontinence Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Medicines for Urge Incontinence Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Medicines for Urge Incontinence Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Medicines for Urge Incontinence Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Medicines for Urge Incontinence Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Medicines for Urge Incontinence Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Medicines for Urge Incontinence Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Medicines for Urge Incontinence Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Medicines for Urge Incontinence Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Medicines for Urge Incontinence Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Medicines for Urge Incontinence Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Medicines for Urge Incontinence Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Medicines for Urge Incontinence Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Medicines for Urge Incontinence Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Medicines for Urge Incontinence Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Medicines for Urge Incontinence Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Medicines for Urge Incontinence Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Medicines for Urge Incontinence Raw Material
Table 121. Key Manufacturers of Medicines for Urge Incontinence Raw Materials
Table 122. Medicines for Urge Incontinence Typical Distributors
Table 123. Medicines for Urge Incontinence Typical Customers
List of Figures
Figure 1. Medicines for Urge Incontinence Picture
Figure 2. Global Medicines for Urge Incontinence Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medicines for Urge Incontinence Consumption Value Market Share by Type in 2022
Figure 4. Anticholinergics Examples
Figure 5. Beta-3 Agonists Examples
Figure 6. Other Examples
Figure 7. Global Medicines for Urge Incontinence Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Medicines for Urge Incontinence Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Medicines for Urge Incontinence Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Medicines for Urge Incontinence Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Medicines for Urge Incontinence Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Medicines for Urge Incontinence Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Medicines for Urge Incontinence Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Medicines for Urge Incontinence Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Medicines for Urge Incontinence by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Medicines for Urge Incontinence Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Medicines for Urge Incontinence Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Medicines for Urge Incontinence Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Medicines for Urge Incontinence Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Medicines for Urge Incontinence Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Medicines for Urge Incontinence Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Medicines for Urge Incontinence Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Medicines for Urge Incontinence Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Medicines for Urge Incontinence Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Medicines for Urge Incontinence Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Medicines for Urge Incontinence Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Medicines for Urge Incontinence Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Medicines for Urge Incontinence Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Medicines for Urge Incontinence Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Medicines for Urge Incontinence Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Medicines for Urge Incontinence Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Medicines for Urge Incontinence Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Medicines for Urge Incontinence Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Medicines for Urge Incontinence Consumption Value Market Share by Region (2018-2029)
Figure 54. China Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Medicines for Urge Incontinence Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Medicines for Urge Incontinence Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Medicines for Urge Incontinence Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Medicines for Urge Incontinence Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Medicines for Urge Incontinence Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Medicines for Urge Incontinence Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Medicines for Urge Incontinence Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Medicines for Urge Incontinence Market Drivers
Figure 75. Medicines for Urge Incontinence Market Restraints
Figure 76. Medicines for Urge Incontinence Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medicines for Urge Incontinence in 2022
Figure 79. Manufacturing Process Analysis of Medicines for Urge Incontinence
Figure 80. Medicines for Urge Incontinence Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source